Systemic lupus erythematosus complicated with thymoma and pure red cell aplasia (PCRA). CR of both complications following thymectomy and allogeneic haematopoietic SCT (HSCT), but persistence of antinuclear antibodies (ANA)

Bone Marrow Transplantation

Volumn 49, Issue 7, 2014, Pages 982-983

  Marmont, A M ^a   Bacigalupo, A ^a   Gualandi, F ^a   Bregante, S ^a   Van Lint, M T ^a   Geroldi, S ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; FLUDARABINE; HEMOGLOBIN; LYMPHOCYTE ANTIBODY;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY BLOOD LEVEL; ARTHRALGIA; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; LETTER; LEUKOCYTE COUNT; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTOPENIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMECTOMY; THYMOMA; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; BLOOD; COMPLICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PROCEDURES; RED-CELL APLASIA, PURE;

ANTIBODIES, ANTINUCLEAR; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RED-CELL APLASIA, PURE; THYMECTOMY; THYMOMA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 84903889717     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.68     Document Type: Letter

References (10)

1. Bozzolo E, Bellone M, Quaroni N, Voci C, Sabbadini MG. Thymoma associated with systemic lupus erythematosus and hematologic abnormalities. Lupus 2000; 9: 151-154.
2. Marmont AM. Therapy of pure red cell aplasia. Sem Hematol 1991; 28: 285-297.
3. Habibi GS, Saliba WR, Froom P. Pure red cell aplasia and lupus. Sem Arthritis Rheum 2002; 31: 279-283.
4. Duchmann R, Schwarting A, Poralia T, Meyer zum Buschenfelde KH, Hermann E. Thymoma and pure red cell aplasia in a patient with systemic lupus erythematosus. Scand J Rheumatol 1995; 24: 251-254.
5. Boonen A, Rennenberg R, van der Linden S. Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature. Rheumatology 2000; 39: 1044-1046.
6. Illei G, Cervera R, Burt RK, Doria A, Hiepe F, Jayne D et al. Current status and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus. Arch Rheum Dis 2011; 70: 2071-2074.
7. Marmont AM. Hematopoietic stem cell transplantation for systemic lupus erythematosus. Clin Dev Immunol 2012; 2: 380-391.
8. Smith-Berdan S, Gille D, Weissmann L, Christensen JL. Reverse of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic stem cells. Blood 2007; 110: 1370-1378.
9. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Ann Rev Immunol 2005; 23: 367-380.
10. Rosario C, Segura E, Vasconcelos C, Shoenfeld Y. Is there a cure for systemic lupus erythematosus? Lupus 2013; 22: 417-421.